Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy

BJU International

Volumn 114, Issue 1, 2014, Pages 56-61

  Xylinas, Evanguelos ^k   Kluth, Luis A ^c   Rieken, Malte ^d   Lee, Richard K ^a   Elghouayel, Maya ^a   Ficarra, Vicenzo ^e   Margulis, Vitaly ^f   Lotan, Yair ^f   Rouprêt, Morgan ^g   Martinez Salamanca, Juan I ^h   Matsumoto, Kazumasa ⁱ   Seitz, Christian ^a   Karakiewicz, Pierre I ^j   Zerbib, Marc ^b   Scherr, Douglas S ^a   Shariat, Shahrokh F ^a,j  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Department of Urology Cochin Hospital APHP Paris Descartes University ^*  (France)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e UNIVERSITY OF PADOVA   (Italy)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

ⁱ KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j UNIVERSITÉ DE MONTRÉAL   (Canada)

^k NEW YORK PRESBYTERIAN HOSPITAL   (United States)

more..

Author keywords

intravesical recurrence; radical nephroureterectomy; smoking; upper tract urothelial carcinoma

Indexed keywords

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; CUMULATIVE SMOKING EXPOSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; EXPOSURE; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAVESICAL RECURRENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); NEPHROURETERECTOMY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITY OF CIGARETTES SMOKED PER DAY; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK REDUCTION; SMOKING; SMOKING CESSATION; SMOKING DURATION; SMOKING HABIT; SURVIVAL RATE; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA;

INTRAVESICAL RECURRENCE; RADICAL NEPHROURETERECTOMY; SMOKING; UPPER TRACT UROTHELIAL CARCINOMA;

DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; RISK FACTORS; SMOKING; TIME FACTORS; TREATMENT OUTCOME; URETER; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 84903306830     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12400     Document Type: Article

References (18)

1. Colin P, Koenig P, Ouzzane A, et al. Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int 2009; 104: 1436-1440
2. Roupret M, Zigeuner R, Palou J, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 2011; 59: 584-594
3. Crivelli JJ, Xylinas E, Kluth LA, Rieken M, Rink M, Shariat SF,. Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature. Eur Urol 2013. doi: 10.1016/j.eururo.2013.06.010 [Epub ahead of print]
4. Rink M, Xylinas E, Margulis V, et al. Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. Eur Urol 2013; 63: 1082-1090
5. Raman JD, Sosa RE, Vaughan ED Jr, Scherr DS,. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma. Urology 2007; 69: 251-254
6. Novara G, De Marco V, Dalpiaz O, et al. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract. BJU Int 2008; 101: 1368-1374
7. Pieras E, Frontera G, Ruiz X, Vicens A, Ozonas M, Piza P,. Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma. BJU Int 2010; 106: 1319-1323
8. Xylinas E, Rink M, Cha EK, et al. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol 2012. doi: 10.1016/j.eururo.2012.04.052 [Epub ahead of print]
9. Xylinas E, Colin P, Audenet F, et al. Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study. World J Urol 2013; 31: 61-68
10. O'Brien T, Ray E, Singh R, Coker B, Beard R,. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur Urol 2011; 60: 703-710
11. Ito A, Shintaku I, Satoh M, et al. Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. J Clin Oncol 2013; 31: 1422-1427
12. Hagiwara M, Kikuchi E, Tanaka N, et al. Impact of smoking status on bladder recurrence following radical nephroureterectomy in patients with upper tract urothelial carcinoma. J Urol 2013; 189: 2062-2068
13. Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 2009; 115: 1224-1233
14. Rink M, Zabor EC, Furberg H, et al. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. Eur Urol 2013; 64: 456-464
15. Rink M, Furberg H, Zabor EC, et al. Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer. Eur Urol 2013; 63: 724-732
16. Ehdaie B, Furberg H, Zabor EC, et al. Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma. BJU Int 2013; 111: 589-595
17. Xylinas E, Rink M, Margulis V, Karakiewicz P, Novara G, Shariat SF,. Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence. Eur Urol 2012; 61: 1069-1070
18. Otto W, Shariat SF, Fritsche HM, et al. Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients. World J Urol 2011; 29: 487-494